As of April 2024 Biocept has a market cap of $1.14 Million. This makes Biocept the world's 8342th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.14 M | 0% |
2023 | $1.14 M | -87.37% |
2022 | $9.04 M | -85.17% |
2021 | $60.96 M | 2.5% |
2020 | $59.48 M | 279.95% |
2019 | $15.65 M | 293.19% |
2018 | $3.98 M | -83.69% |
2017 | $24.41 M | 80.02% |
2016 | $13.56 M | -50.04% |
2015 | $27.14 M | 145.99% |
2014 | $11.03 M |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Veracyte VCYT | $1.44 B | 126,397.73% | ๐บ๐ธ USA |
Exact Sciences EXAS | $10.64 B | 931,747.26% | ๐บ๐ธ USA |
Myriad Genetics MYGN | $1.64 B | 143,532.70% | ๐บ๐ธ USA |